Counterpoint Global
North America, New York, United States, New York
Description
Counterpoint Global is a fundamental equities team at Morgan Stanley focused on long-term investing.
Investor Profile
Counterpoint Global has backed more than 28 startups, with 3 new investments in the last 12 months alone. The firm has led 3 rounds, about 11% of its total and boasts 11 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity, Series C, Series D rounds (top funding stages).
- Majority of deals are located in United States, Singapore, United Kingdom.
- Strong thematic focus on Software, Biotechnology, Artificial Intelligence (AI).
Stage Focus
- Post Ipo Equity (32%)
- Series C (21%)
- Series D (18%)
- Series F (7%)
- Series E (7%)
- Series I (4%)
- Series G (4%)
- Series H (4%)
- Series Unknown (4%)
Country Focus
- United States (86%)
- Singapore (4%)
- United Kingdom (4%)
- Canada (4%)
- Israel (4%)
Industry Focus
- Software
- Biotechnology
- Artificial Intelligence (Ai)
- Health Diagnostics
- Analytics
- Machine Learning
- Predictive Analytics
- Information Technology
- Health Care
- Digital Media
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Counterpoint Global frequently co-invest with?
Which angels does Counterpoint Global often collaborate with?
What are some of recent deals done by Counterpoint Global?
Find More Investors Like Counterpoint Global
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
















